Charles L. Sawyers

Publishes on Prostate Cancer Treatment and Research, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research. 639 papers and 104.2k citations.

PubIndex Score98Top 2%How it's scored

🌟#1 Current Senior Leader in Prostate Cancer Treatment and Research 🌟#4 Current Senior Leader in Cancer, Lipids, and Metabolism 🌟#4 Current Senior Leader in Chronic Myeloid Leukemia Treatments 🌟#4 Current Senior Leader in Hormonal and reproductive studies

639Publications

104.2kTotal Citations

#1in Prostate Cancer Treatment and Research

First publication: 1986First senior author: 1994

Prostate Cancer Treatment and Research Chronic Myeloid Leukemia Treatments Chronic Lymphocytic Leukemia Research Cancer Genomics and Diagnostics PI3K/AKT/mTOR signaling in cancer

Top publicationsby citations

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

Neil P. Shah, Charles L. Sawyers, John Nicoll et al.|Cancer Cell|2002

Cited by 1.6k

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Dong Gao, Yu Chen, Jackline Wanjala et al.|Cell|2014

Cited by 1.6k

Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors

Ingo K. Mellinghoff, Paul S. Mischel, Maria Y. Wang et al.|New England Journal of Medicine|2005

Cited by 1.4k

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

Howard I. Scher, Charles L. Sawyers, Tomasz M. Beer et al.|The Lancet|2010

Cited by 1.1k

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway

Xinyi Wu, Charles L. Sawyers|Proceedings of the National Academy of Sciences|1998

Cited by 691